0
Business
Roche to Buy PathAI for Up to $1.05 Billion to Bolster AI Diagnostics Tools
May 7, 2026
Scroll
Posted 1 hour ago by
The deal seeks to bolster the artificial-intelligence offerings of Roche’s diagnostics division, helping to accelerate clinical-therapy development.
The Wall Street Journal - Business
Coverage and analysis from United States of America. All insights are generated by our AI narrative analysis engine.
United States of America
Bias: lean right
People's Voices (0)
Leave a comment
0/500
Note: Comments are moderated. Please keep it civil. Max 3 comments per day.